Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
1 clinical trials · Condition
◉ Watch Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
| Record | Firm | Date |
|---|---|---|
| An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL (NCT06015464) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-01 |
Track Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type automatically
Every clearance here is in the API, with alerts when new ones post.